Skip to main content
Have a personal or library account? Click to login
Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature Cover

Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature

Radiology and Oncology
Volume 46 (2012): Issue 3 (September 2012)
By: ,  ,  ,   and    
Open Access
|Jan 2012
References

References

  1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma.1956;: 822-30.
    Open DOISearch in Google Scholar
  2. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia.1978;: 86-90.
    Open DOISearch in Google Scholar
  3. Soulier J, Grollet L, Oksenhendler E, Miclea JM, Cacoub P, Baruchel A, et al. Molecular analysis of clonality in Castleman's disease.1995;: 1131-8.
    Open DOISearch in Google Scholar
  4. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.1995;: 1276-80.
    Open DOISearch in Google Scholar
  5. Gessain A, Sudaka A, Brière J, Fouchard N, Nicola MA, Rio B, et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients?1996;: 414-6.
    Open DOISearch in Google Scholar
  6. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease.1998;: 657-62.
    Open DOISearch in Google Scholar
  7. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.2005;: 3-17.
    Open DOISearch in Google Scholar
  8. Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman's disease.1992;: 850-5.
    Search in Google Scholar
  9. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease).1995;: 291-310.
    Open DOISearch in Google Scholar
  10. Shahidi H, Myers JL, Kvale PA. Castleman's disease.1995;: 969-77.
    Open DOISearch in Google Scholar
  11. Neuhof D, Debus J. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease.2006;: 1126-31.
    Open DOISearch in Google Scholar
  12. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.2001;: 670-6.
    Open DOISearch in Google Scholar
  13. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.1999;: 706-17.
    Open DOISearch in Google Scholar
  14. de Vries IA, van Acht MM, Demeyere TB, Lybeert ML, de Zoete JP, Nieuwenhuijzen GA. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.2010;: 7.
    Open DOISearch in Google Scholar
  15. Peterson BA, Frizzera G. Multicentric Castleman's disease.1993;: 636-47.
    Search in Google Scholar
  16. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.1972;: 670-83.
    Open DOISearch in Google Scholar
  17. Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients.2010;: 1171-8.
    Open DOISearch in Google Scholar
  18. Lin CY, Chang YL. Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review.2010;: 913-20.
    Open DOISearch in Google Scholar
  19. Paumier A, Ghalibafian M, Beaudre A, Ferreira I, Pichenot C, Messai T, et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.2011;: 199-205.
    Open DOISearch in Google Scholar
  20. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study.2011;: 1336-42.
    Open DOISearch in Google Scholar
  21. Lievens Y, Nulens A, Gaber MA, Defraene G, De Wever W, Stroobants S, et al. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.2011;: 306-13.
    Open DOISearch in Google Scholar
  22. Banu A, Enis O, Kaan G, Gungor G. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma.2010;: 194-8.
    Search in Google Scholar
  23. Bailey DW, Lalith K; Podgorsak MB. A fully electronic intensity-modulated radiation therapy quality assurance (IMRT) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems.2010;: 124-30.
    Search in Google Scholar
  24. Śladowska A, Hetnał M, Dymek P, Kabat D, Kisielewicz K, Wawrzak M, et al. Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh - preliminary results.2011;: 110-4.
    Open DOISearch in Google Scholar
  25. Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy.1979;: 457-62.
    Open DOISearch in Google Scholar
  26. Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy.1978;: 169-71.
    Open DOISearch in Google Scholar
  27. Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy.1983;: 808-10.
    Open DOISearch in Google Scholar
  28. Veldhuis GJ, van der Leest AH, de Wolf JT, de Vries EG, Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects.1996;: 47-50.
    Open DOISearch in Google Scholar
  29. Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.1994;: 602-5.
    Open DOISearch in Google Scholar
  30. Li X, Wang X, Li Y, Zhang X. A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques.2011;: 83.
    Open DOISearch in Google Scholar
  31. Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors.2006;: 255-65.
    Open DOISearch in Google Scholar
  32. Suciu D. Cellular death by apoptosis in some radiosensitive and radioresistant mammalian tissues.1983;: 391-401.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-012-0008-0 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 265 - 270
Published on: Jan 2, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Castleman's disease,
IMRT
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2012 Chance Matthiesen, Rajeev Ramgopol, Jonathan Seavey, Salahuddin Ahmad, Terence Herman, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 3 (September 2012)
Previous article